Higher vs. Lower Dose Heparin for PCI

• Status: Not yet recruiting
• Trial end date: 2023-05-01
• Target enrollment: 0
• Participant gender: All

Summary

HD PCI is a multicenter, randomized, registry-based, cluster crossover design trial of higher dose versus lower dose heparin in patients undergoing elective percutaneous coronary intervention (PCI).

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Population Health Research Institute
• Treatments: Calcium heparin; Heparin

Criteria

Inclusion Criteria:

• Patients undergoing elective PCI

Exclusion Criteria:

• Age <18 years

• Planned chronic total occlusion PCI

• Non-resident precluding follow up through local registries

Hospital (Cluster) Eligibility Criteria

Hospitals will be eligible to participate if they meet the following criteria:

• Submit PCI procedure data to a compatible registry that is able to provide data for the trial

• Site agrees to manage patients as per the higher or lower dose heparin policy in place during the given crossover period